J. D. Finley
CEO, CFO & DirectorMr. J. D. Finley, MT, serves as its Chief Executive Officer of Palisade Bio, Inc. since 2023 and has been its Director since February 2023. He serves as the Chief Financial Officer at Palisade Bio, Inc. (Alternate name: Leading BioSciences, Inc) since April 27, 2021 and served as its Principal Financial and Accounting Officer and served as its Interim Chief Executive Officer since October 11, 2022 until 2023. Over his career, he has internal Chief Financial Officer and as an independent investment banker. Mr. Finley began his business career as a tax specialist with Deloitte & Haskins and Sells (now Deloitte & Touche) and later was co-owner of Mitchell Finley & Company, full-service accounting firm. After successful years in public accounting, Mr. Finley joined MetroGolf, Inc. as its Executive Vice President and Chief Financial Officer where he successfully completed MetroGolf’s initial public offering and was instrumental in growing the start-up company to over 125 employees. Previously, Mr. Finley served as LBS’s Chief Financial Officer since January 2017 and as a member of board of directors of LBS (the “LBS Board”) since December 2014. Upon the sale of MetroGolf, Mr. Finley joined Phillips Capital, broker/dealer firm specializing in private debt and equity capital raises. In January 2006 Mr. Finley co-founded Proteus Capital Partners, Inc. He served as Director of Leading BioSciences Inc. Prior to joining Leading BioSciences, Mr. Finley was the CEO, President and CFO for PointAcross, Inc., a software company providing business messaging and communications services from January 2016 to January 2017. From March 2011 to June 2012 Mr. Finley was Executive Vice President and from June 2012 to April 2014 Mr. Finley was President of Goldmail. Mr. Finley received a B.A. in business administration from Boise State University and an M.S in taxation from the University of Denver.
Positions
- Company NamePalisade Bio, Inc.Stock CodePALIPositionCEO, CFO & DirectorColleagues
- DADonald A. WilliamsIndependent Chairman of the Board
- MLMitchell Lawrence JonesPresident & Chief Medical Officer
- RCRamesh C. DonthamsettyHead of IR and Corporate Strategy
- JEJulien E. CapersGeneral Counsel & Corporate Secretary
- JHJoerg HeyerHead of Translational Science & Medicine
- ECEmil ChuangIndependent Director
- BWBinxian WeiIndependent Director
- BEBruce E. SandsMember of Clinical Advisory Board
